The US FDA has approved CSL's HEMGENIX (etranacogene dezaparvovec-drlb) as the first and only one-time gene therapy for appropriate adults with haemophilia B. …
CSL secures US approval for breakthrough one-time haemophilia gene therapy
November 24, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Week in Review' Podcast - 21 February
February 21, 2025 - - Podcast -
PSA members endorse acquisition of the Australasian College of Pharmacy
February 21, 2025 - - Latest News -
Significant gift new Academy for Health Leadership at University of Melbourne
February 21, 2025 - - Latest News -
First and only treatment for chronic hypoparathyroidism approved in Australia
February 21, 2025 - - Latest News -
AstraZeneca maintains its lead as other teams start to build
February 21, 2025 - - Latest News -
A good idea that will need to overcome an institutional mindset
February 19, 2025 - - Latest News -
Pharmaceuticals the latest Trump target for tariffs
February 19, 2025 - - Latest News